Connexin 43 gene therapy prevents persistent atrial fibrillation in a porcine model

Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia, and effective treatment of AF still remains an unmet medical need. AF is associated with atrial conduction disturbances caused by electrical and/or structural remodelling. We hypothesized that AF suppresses expression of the g...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Bikou, Olympia (VerfasserIn) , Thomas, Dierk (VerfasserIn) , Trappe, Kerstin (VerfasserIn) , Lugenbiel, Patrick (VerfasserIn) , Kelemen, Kamilla (VerfasserIn) , Koch, Martin Christoph (VerfasserIn) , Soucek, Radim (VerfasserIn) , Voss, Frederik (VerfasserIn) , Becker, Rüdiger (VerfasserIn) , Katus, Hugo (VerfasserIn) , Bauer, Alexander (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 28 July 2011
In: Cardiovascular research
Year: 2011, Jahrgang: 92, Heft: 2, Pages: 218-225
ISSN:1755-3245
DOI:10.1093/cvr/cvr209
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1093/cvr/cvr209
Volltext
Verfasserangaben:Olympia Bikou, Dierk Thomas, Kerstin Trappe, Patrick Lugenbiel, Kamilla Kelemen, Martin Koch, Radim Soucek, Frederik Voss, Rüdiger Becker, Hugo A. Katus, and Alexander Bauer

MARC

LEADER 00000caa a2200000 c 4500
001 1796411418
003 DE-627
005 20220820152250.0
007 cr uuu---uuuuu
008 220323s2011 xx |||||o 00| ||eng c
024 7 |a 10.1093/cvr/cvr209  |2 doi 
035 |a (DE-627)1796411418 
035 |a (DE-599)KXP1796411418 
035 |a (OCoLC)1341457879 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Bikou, Olympia  |e VerfasserIn  |0 (DE-588)1024753360  |0 (DE-627)720453569  |0 (DE-576)36944096X  |4 aut 
245 1 0 |a Connexin 43 gene therapy prevents persistent atrial fibrillation in a porcine model  |c Olympia Bikou, Dierk Thomas, Kerstin Trappe, Patrick Lugenbiel, Kamilla Kelemen, Martin Koch, Radim Soucek, Frederik Voss, Rüdiger Becker, Hugo A. Katus, and Alexander Bauer 
264 1 |c 28 July 2011 
300 |a 8 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 23.03.2022 
520 |a Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia, and effective treatment of AF still remains an unmet medical need. AF is associated with atrial conduction disturbances caused by electrical and/or structural remodelling. We hypothesized that AF suppresses expression of the gap junction protein connexin (Cx) 43 and that Cx43 gene transfer to both atria would prevent persistent AF. The first aim of this study was to assess whether AF is associated with connexin remodelling in a porcine model. A strategy to suppress persistent AF by gene therapy was then developed and evaluated in vivo.AF was induced in domestic pigs via atrial burst pacing, causing a 62.4% reduction in atrial Cx43 protein. Adenoviruses encoding for Cx43 (AdCx43) or green fluorescent protein (AdGFP) were injected into both atria, followed by epicardial electroporation to enhance transgene expression. Combining direct injection of adenoviruses with electroporation achieved GFP reporter gene expression in ∼50% of atrial cells in vivo. AdCx43-treated animals exhibited a 2.5-fold increase in atrial Cx43 protein content and did not develop persistent AF during the observation period of 14 days. In contrast, control animals developed persistent AF within 7.4 ± 0.5 days. Rapid ventricular heart rates during AF led to deterioration of cardiac function in control pigs but not in pigs treated with AdCx43.Our results highlight the contribution of Cx43 to the pathophysiology of AF and demonstrate the viability of gene therapy for prevention of atrial arrhythmias. 
700 1 |a Thomas, Dierk  |d 1974-  |e VerfasserIn  |0 (DE-588)123896258  |0 (DE-627)706465601  |0 (DE-576)29393164X  |4 aut 
700 1 |a Trappe, Kerstin  |d 1981-  |e VerfasserIn  |0 (DE-588)14081616X  |0 (DE-627)622582240  |0 (DE-576)320910229  |4 aut 
700 1 |a Lugenbiel, Patrick  |d 1982-  |e VerfasserIn  |0 (DE-588)137855710  |0 (DE-627)696120062  |0 (DE-576)305349414  |4 aut 
700 1 |a Kelemen, Kamilla  |d 1976-  |e VerfasserIn  |0 (DE-588)129031933  |0 (DE-627)387884386  |0 (DE-576)29745742X  |4 aut 
700 1 |a Koch, Martin Christoph  |d 1981-  |e VerfasserIn  |0 (DE-588)144027224  |0 (DE-627)656818379  |0 (DE-576)340416262  |4 aut 
700 1 |a Soucek, Radim  |d 1983-  |e VerfasserIn  |0 (DE-588)1020322519  |0 (DE-627)691180059  |0 (DE-576)357985729  |4 aut 
700 1 |a Voss, Frederik  |d 1968-  |e VerfasserIn  |0 (DE-588)122527364  |0 (DE-627)705940152  |0 (DE-576)293308845  |4 aut 
700 1 |a Becker, Rüdiger  |e VerfasserIn  |0 (DE-588)1032502541  |0 (DE-627)738501409  |0 (DE-576)380071061  |4 aut 
700 1 |a Katus, Hugo  |d 1951-  |e VerfasserIn  |0 (DE-588)108916618  |0 (DE-627)577155040  |0 (DE-576)289625076  |4 aut 
700 1 |a Bauer, Alexander  |d 1966-  |e VerfasserIn  |0 (DE-588)115589082  |0 (DE-627)691434549  |0 (DE-576)289965233  |4 aut 
773 0 8 |i Enthalten in  |t Cardiovascular research  |d Oxford : Oxford University Press, 1967  |g 92(2011), 2, Seite 218-225  |h Online-Ressource  |w (DE-627)306654393  |w (DE-600)1499917-1  |w (DE-576)081984685  |x 1755-3245  |7 nnas  |a Connexin 43 gene therapy prevents persistent atrial fibrillation in a porcine model 
773 1 8 |g volume:92  |g year:2011  |g number:2  |g pages:218-225  |g extent:8  |a Connexin 43 gene therapy prevents persistent atrial fibrillation in a porcine model 
856 4 0 |u https://doi.org/10.1093/cvr/cvr209  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20220323 
993 |a Article 
994 |a 2011 
998 |g 115589082  |a Bauer, Alexander  |m 115589082:Bauer, Alexander  |d 50000  |e 50000PB115589082  |k 0/50000/  |p 11  |y j 
998 |g 108916618  |a Katus, Hugo  |m 108916618:Katus, Hugo  |d 910000  |d 910100  |e 910000PK108916618  |e 910100PK108916618  |k 0/910000/  |k 1/910000/910100/  |p 10 
998 |g 1032502541  |a Becker, Rüdiger  |m 1032502541:Becker, Rüdiger  |d 910000  |d 910100  |d 50000  |e 910000PB1032502541  |e 910100PB1032502541  |e 50000PB1032502541  |k 0/910000/  |k 1/910000/910100/  |k 0/50000/  |p 9 
998 |g 122527364  |a Voss, Frederik  |m 122527364:Voss, Frederik  |d 50000  |e 50000PV122527364  |k 0/50000/  |p 8 
998 |g 1020322519  |a Soucek, Radim  |m 1020322519:Soucek, Radim  |d 50000  |e 50000PS1020322519  |k 0/50000/  |p 7 
998 |g 144027224  |a Koch, Martin Christoph  |m 144027224:Koch, Martin Christoph  |d 50000  |e 50000PK144027224  |k 0/50000/  |p 6 
998 |g 129031933  |a Kelemen, Kamilla  |m 129031933:Kelemen, Kamilla  |d 910000  |d 910100  |d 50000  |e 910000PK129031933  |e 910100PK129031933  |e 50000PK129031933  |k 0/910000/  |k 1/910000/910100/  |k 0/50000/  |p 5 
998 |g 137855710  |a Lugenbiel, Patrick  |m 137855710:Lugenbiel, Patrick  |d 910000  |d 910100  |e 910000PL137855710  |e 910100PL137855710  |k 0/910000/  |k 1/910000/910100/  |p 4 
998 |g 14081616X  |a Trappe, Kerstin  |m 14081616X:Trappe, Kerstin  |d 910000  |d 910100  |e 910000PT14081616X  |e 910100PT14081616X  |k 0/910000/  |k 1/910000/910100/  |p 3 
998 |g 123896258  |a Thomas, Dierk  |m 123896258:Thomas, Dierk  |d 910000  |d 910100  |e 910000PT123896258  |e 910100PT123896258  |k 0/910000/  |k 1/910000/910100/  |p 2 
998 |g 1024753360  |a Bikou, Olympia  |m 1024753360:Bikou, Olympia  |d 910000  |d 910100  |d 50000  |e 910000PB1024753360  |e 910100PB1024753360  |e 50000PB1024753360  |k 0/910000/  |k 1/910000/910100/  |k 0/50000/  |p 1  |x j 
999 |a KXP-PPN1796411418  |e 4098160692 
BIB |a Y 
SER |a journal 
JSO |a {"note":["Gesehen am 23.03.2022"],"name":{"displayForm":["Olympia Bikou, Dierk Thomas, Kerstin Trappe, Patrick Lugenbiel, Kamilla Kelemen, Martin Koch, Radim Soucek, Frederik Voss, Rüdiger Becker, Hugo A. Katus, and Alexander Bauer"]},"title":[{"title":"Connexin 43 gene therapy prevents persistent atrial fibrillation in a porcine model","title_sort":"Connexin 43 gene therapy prevents persistent atrial fibrillation in a porcine model"}],"language":["eng"],"physDesc":[{"extent":"8 S."}],"origin":[{"dateIssuedKey":"2011","dateIssuedDisp":"28 July 2011"}],"id":{"eki":["1796411418"],"doi":["10.1093/cvr/cvr209"]},"recId":"1796411418","relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title":"Cardiovascular research","title_sort":"Cardiovascular research"}],"language":["eng"],"note":["Gesehen am 01.12.2020"],"origin":[{"publisher":"Oxford University Press ; Elsevier Science","publisherPlace":"Oxford ; Amsterdam [u.a.]","dateIssuedKey":"1967","dateIssuedDisp":"1967-"}],"id":{"zdb":["1499917-1"],"eki":["306654393"],"issn":["1755-3245"]},"part":{"volume":"92","pages":"218-225","issue":"2","extent":"8","year":"2011","text":"92(2011), 2, Seite 218-225"},"disp":"Connexin 43 gene therapy prevents persistent atrial fibrillation in a porcine modelCardiovascular research","pubHistory":["1.1967 -"],"type":{"bibl":"periodical","media":"Online-Ressource"},"recId":"306654393"}],"person":[{"role":"aut","display":"Bikou, Olympia","family":"Bikou","given":"Olympia"},{"role":"aut","display":"Thomas, Dierk","family":"Thomas","given":"Dierk"},{"given":"Kerstin","family":"Trappe","display":"Trappe, Kerstin","role":"aut"},{"role":"aut","display":"Lugenbiel, Patrick","family":"Lugenbiel","given":"Patrick"},{"given":"Kamilla","role":"aut","display":"Kelemen, Kamilla","family":"Kelemen"},{"role":"aut","family":"Koch","display":"Koch, Martin Christoph","given":"Martin Christoph"},{"given":"Radim","display":"Soucek, Radim","family":"Soucek","role":"aut"},{"given":"Frederik","display":"Voss, Frederik","family":"Voss","role":"aut"},{"given":"Rüdiger","family":"Becker","display":"Becker, Rüdiger","role":"aut"},{"role":"aut","family":"Katus","display":"Katus, Hugo","given":"Hugo"},{"given":"Alexander","display":"Bauer, Alexander","family":"Bauer","role":"aut"}],"type":{"media":"Online-Ressource","bibl":"article-journal"}} 
SRT |a BIKOUOLYMPCONNEXIN432820